| Abstract: | Our aim was to study the effect of a mucosal protective agent, rebamipide, on the colonic barrier and the immune response
in colitis-prone interleukin-10-deficient (IL-10−/−) C57BL/6 mice infected with Helicobacter hepaticus. After sacrifice, in all mice, control, or previously infected with H. hepaticus, or previously infected and treated with rebamipide enema, a histological examination of colonic samples was performed, intestinal
permeability was studied in Ussing chamber, and mesenteric lymph node proliferation and cytokine secretion were measured.
Mice treated with rebamipide presented a reinforcement of the distal colonic epithelial barrier, an increase of mesenteric
lymph node cells proliferation, and of IFNγ and IL-12 secretion. These results indicate that in IL-10−/− mice with mild colitis,
rectally administered rebamipide reinforces the distal colonic barrier and has a slight Th1 immuno-stimulatory effect on mesenteric
lymph node cells. These properties could be helpful in the management of some inflammatory bowel diseases. |
